Monthly cabotegravir-rilpivirine injections superior to standard oral ART for HIV with adherence challenges
Medical Xpress
February 27, 2026
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) and medication adherence challenges, according to a study published online Feb. 18 in the New England Journal of Medicine.
Verticals
healthmedical
Originally published on Medical Xpress on 2/27/2026